These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8258191)

  • 1. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133.
    Stekar J; Hilgard P; Voegeli R; Maurer HR; Engel J; Kutscher B; Nössner G; Schumacher W
    Cancer Chemother Pharmacol; 1993; 32(6):437-44. PubMed ID: 8258191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-21266, a new heterocyclic alkylphospholipid with antitumour activity.
    Hilgard P; Klenner T; Stekar J; Nössner G; Kutscher B; Engel J
    Eur J Cancer; 1997 Mar; 33(3):442-6. PubMed ID: 9155530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P; Berger MR; Unger C; Eibl H
    Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies.
    Konstantinov SM; Kaminsky R; Brun R; Berger MR; Zillmann U
    Acta Trop; 1997 Apr; 64(3-4):145-54. PubMed ID: 9107362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).
    Hilgard P; Stekar J; Voegeli R; Engel J; Schumacher W; Eibl H; Unger C; Berger MR
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1457-61. PubMed ID: 3141197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkyl phosphocholines: toxicity and anticancer properties.
    Muschiol C; Berger MR; Schuler B; Scherf HR; Garzon FT; Zeller WJ; Unger C; Eibl HJ; Schmähl D
    Lipids; 1987 Nov; 22(11):930-4. PubMed ID: 3444388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA).
    Uchida M; Tsuboi H; Yamaji T; Murata N; Kohno T; Sugino E; Hibino S; Shimamura M; Oikawa T
    Cancer Lett; 2000 Jun; 154(1):63-9. PubMed ID: 10799740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
    Yanapirut P; Berger MR; Reinhardt M; Schmähl D
    Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo.
    Unger C; Damenz W; Fleer EA; Kim DJ; Breiser A; Hilgard P; Engel J; Nagel G; Eibl H
    Acta Oncol; 1989; 28(2):213-7. PubMed ID: 2736110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin.
    Singletary K; MacDonald C; Wallig M; Fisher C
    Cancer Lett; 1996 Jun; 103(2):137-41. PubMed ID: 8635149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of four anti-cancer alkylphosphocholine derivatives in vitro and in vivo.
    Sobottka SB; Berger MR; Eibl H
    Int J Cancer; 1993 Feb; 53(3):418-25. PubMed ID: 8428795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas.
    Berger MR; Yanapirut P; Reinhardt M; Klenner T; Scherf HR; Schmeiser HH; Eibl H
    Prog Exp Tumor Res; 1992; 34():98-115. PubMed ID: 1438807
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P; Drevs J; Berger MR; Kötting J; Marschner N; Unger C; Eibl H
    Cancer Chemother Pharmacol; 1994; 34(5):393-8. PubMed ID: 8070005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
    J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.
    Alshafie GA; Abou-Issa HM; Seibert K; Harris RE
    Oncol Rep; 2000; 7(6):1377-81. PubMed ID: 11032948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans- and 13-cis-retinoic acids on rat breast cancer.
    Teelmann K; Tsukaguchi T; Klaus M; Eliason JF
    Cancer Res; 1993 May; 53(10 Suppl):2319-25. PubMed ID: 8485719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of mammary epithelial cell differentiation and inhibition of dimethylbenz(A)anthracene-induced mammary tumour by co-administration of a pure antiestrogen ICI 182,780 and testosterone enanthate.
    Chan TW; Mark G; Huynh H
    Int J Oncol; 2001 Aug; 19(2):263-9. PubMed ID: 11445837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antitumoral activity of alkylphosphonates.
    Ries UJ; Fleer EA; Breiser A; Unger C; Stekar J; Fenneberg K; Eibl H
    Eur J Cancer; 1992; 29A(1):96-101. PubMed ID: 1445752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rat cell line derived from DMBA-induced mammary carcinoma.
    Chow LW; Cheung MN; Loo WT; Guan XY
    Life Sci; 2003 May; 73(1):27-40. PubMed ID: 12726884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.